Top Ranked Momentum Stocks to Buy for September 2nd

DY GNRC ACEL

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 2nd:

Generac Holdings Inc. (GNRC - Free Report) : This manufacturer and seller of power generation equipment, energy storage systems, and other power products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.2% over the last 60 days.

Generac Holdlings Inc. Price and Consensus

Generac's shares gained 20.7% over the last one month compared to S&P 500’s rise of 8.3%. The company possesses a Momentum Score of B.

Generac Holdlings Inc. Price

Dycom Industries, Inc. (DY - Free Report) : This provider of specialty contracting services in the United States has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 31.2% over the last 60 days.

Dycom Industries, Inc. Price and Consensus

Dycom's shares gained 47% over the last one month. The company possesses a Momentum Score of A.

Dycom Industries, Inc. Price

Accel Entertainment, Inc. (ACEL - Free Report) : This company that is engaged in the distributed gaming operations has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Accel Entertainment, Inc. Price and Consensus

Accel's shares gained 55.1% over the last one month. The company possesses a Momentum Score of A.

Accel Entertainment, Inc. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>